Department of Nephrology, Ningbo No.2 Hospital, Ningbo, Zhejiang Province, People's Republic of China.
PLoS One. 2024 Apr 17;19(4):e0302179. doi: 10.1371/journal.pone.0302179. eCollection 2024.
Acute kidney injury (AKI) is frequent among in-hospital patients with high incidence and mortality. Implementing a series of evidence-based AKI care bundles may improve patient outcomes by reducing changeable standards of care. The aim of this meta-analysis was therefore to appraise the influences of AKI care bundles on patient outcomes.
We explored three international databases (PubMed, Embase, and Cochrane Central Register of Controlled Trials) and two Chinese databases (Wanfang Data and China National Knowledge Infrastructure) for studies from databases inception until November 30, 2022, comparing the impact of different AKI care bundles with usual standards of care in patients with or at risk for AKI. The study quality of non-randomized controlled trials and randomized controlled trials was evaluated by the NIH Study Quality Assessment Tool and the Cochrane risk of bias tool. Heterogeneity between studies was appraised by Cochran's Q test and I2 statistics. The possible origins of heterogeneity between studies were assessed adopting Meta-regression and subgroup analyses. Funnel plot asymmetry and Egger regression and Begg correlation tests were performed to discover potential publication bias. Data analysis was completed by software (RevMan 5.3 and Stata 15.0). The primary outcome was short- or long-term mortality. The secondary outcomes involved the incidence and severity of AKI.
Sixteen studies containing 25,690 patients and 25,903 AKI episodes were included. In high-risk AKI patients determined by novel biomarkers, electronic alert or risk prediction score, the application of AKI care bundles significantly reduced the AKI incidence (OR, 0.71; 95% CI, 0.53-0.96; p = 0.02; I2 = 84%) and AKI severity (OR, 0.59; 95% CI, 0.39-0.89; p = 0.01; I2 = 65%). No strong evidence is available to prove that care bundles can significantly reduce mortality (OR, 1.16; 95% CI, 0.58-2.30; p = 0.68; I2 = 97%).
The introduction of AKI care bundles in routine clinical practice can effectively improve the outcomes of patients with or at-risk of AKI. However, the accumulated evidence is limited and not strong enough to make definite conclusions.
急性肾损伤(AKI)在住院患者中较为常见,发病率和死亡率均较高。实施一系列基于循证的 AKI 护理包可能通过降低可改变的护理标准来改善患者的预后。因此,本荟萃分析的目的是评估 AKI 护理包对患者预后的影响。
我们检索了三个国际数据库(PubMed、Embase 和 Cochrane 对照试验中心注册库)和两个中文数据库(万方数据和中国国家知识基础设施),以获取截至 2022 年 11 月 30 日比较不同 AKI 护理包与 AKI 患者或有 AKI 风险患者常规护理影响的研究。非随机对照试验和随机对照试验的研究质量采用 NIH 研究质量评估工具和 Cochrane 偏倚风险工具进行评估。通过 Cochran's Q 检验和 I2 统计评估研究之间的异质性。采用 Meta 回归和亚组分析评估研究之间异质性的可能来源。采用漏斗图不对称性和 Egger 回归和 Begg 相关检验发现潜在的发表偏倚。数据分析采用软件(RevMan 5.3 和 Stata 15.0)完成。主要结局为短期或长期死亡率。次要结局包括 AKI 的发生率和严重程度。
纳入了 16 项研究,共包含 25690 名患者和 25903 例 AKI 发作。在新型生物标志物、电子警报或风险预测评分确定的高危 AKI 患者中,应用 AKI 护理包可显著降低 AKI 发生率(OR,0.71;95%CI,0.53-0.96;p=0.02;I2=84%)和 AKI 严重程度(OR,0.59;95%CI,0.39-0.89;p=0.01;I2=65%)。没有强有力的证据表明护理包可以显著降低死亡率(OR,1.16;95%CI,0.58-2.30;p=0.68;I2=97%)。
在常规临床实践中引入 AKI 护理包可以有效改善 AKI 患者或有 AKI 风险患者的预后。然而,现有证据有限且不够有力,无法得出明确结论。